Yixin ketone dispersing tablets
A technology of Yixin ketone and dispersible tablets, applied in the field of Yixin ketone dispersible tablets, can solve the problems of difficult industrialization, adhesion, high proportion and content, and achieve the effects of large room for maneuver and improvement of disintegration degree.
- Summary
- Abstract
- Description
- Claims
- Application Information
AI Technical Summary
Problems solved by technology
Method used
Examples
Embodiment 1
[0052] The weight percentage of traditional Chinese medicine extract and auxiliary materials of Yixindone dispersible tablet: 24% of fine powder of Yixindone extract, 22% of low-substituted hydroxypropyl cellulose, 20% of sodium carboxymethyl starch, and 7% of microcrystalline cellulose , lactose 21%, polyvinylpyrrolidone 3%, magnesium stearate 3%.
[0053] Yixindone dispersible tablets are obtained according to the following specific steps: take hawthorn leaves, crush them into coarse powder, use ethanol as a solvent to carry out percolation according to the percolation method under the liquid extract and extract, collect the percolation liquid, and depressurize Recover ethanol to a certain concentration, add an equal amount of water to dilute, add petroleum ether to remove the pigment, separate the water layer, shake and extract with ethyl acetate, extract the ethyl acetate under reduced pressure and concentrate to dryness to obtain total flavonoids, crush The fine powder of...
Embodiment 2
[0056] The fine powder of Yixinone extract by weight 28%, sodium carboxymethylcellulose 22%, microcrystalline cellulose 11%, cross-linked polyvinylpyrrolidone 15%, polyvinylpyrrolidone 5%, lactose 12%, polyethylene Pyrrolidone 4%, micronized silica gel 1%, magnesium lauryl sulfate 2%. All the other are with embodiment 1.
Embodiment 3
[0058] The fine powder of Yixinone extract in percentage by weight 35%, sodium carboxymethyl starch 20%, croscarmellose sodium 15%, crospovidone 6%, low-substituted hydroxypropyl cellulose 3% , mannitol 10%, polyvinylpyrrolidone 7%, micronized silica gel 1%, magnesium stearate 2%, HLB=15-16 sucrose fatty acid ester 1%. Sucrose fatty acid ester is P-1570 or P-1670 or LWA-1570, and all the other are the same as embodiment 1.
PUM
Abstract
Description
Claims
Application Information
- R&D Engineer
- R&D Manager
- IP Professional
- Industry Leading Data Capabilities
- Powerful AI technology
- Patent DNA Extraction
Browse by: Latest US Patents, China's latest patents, Technical Efficacy Thesaurus, Application Domain, Technology Topic, Popular Technical Reports.
© 2024 PatSnap. All rights reserved.Legal|Privacy policy|Modern Slavery Act Transparency Statement|Sitemap|About US| Contact US: help@patsnap.com